Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Accounts Receivable (Quarterly): 0.00 for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.007M |
September 30, 2023 | 0.041M |
June 30, 2023 | 0.062M |
March 31, 2023 | 0.089M |
December 31, 2022 | 0.061M |
September 30, 2022 | 0.215M |
Date | Value |
---|---|
June 30, 2022 | 0.177M |
March 31, 2022 | 0.325M |
December 31, 2021 | 0.357M |
September 30, 2021 | 0.30M |
June 30, 2021 | 0.121M |
March 31, 2021 | |
December 31, 2020 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
0.357M
Maximum
Dec 2021
0.135M
Average
0.089M
Median
Mar 2023
Accounts Receivable (Quarterly) Benchmarks
AstraZeneca PLC | 11.05B |
Landos Biopharma Inc (DELISTED) | -- |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 25.52M |
Edesa Biotech Inc | 0.5511M |